There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...

ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

Sipuleucel-T A therapeutic cancer ... melanoma (ipilimumab) are in Phase III testing in mCRPC and may provide additional immunotherapy options. Emerging Therapies in Prostate Cancer The ...

BMS has bucked the trend for late-stage immuno-oncology studies in prostate cancer in the CheckMate 650 trial Opdivo in combination with CTLA4 inhibitor Yervoy (ipilimumab), which showed modest ...

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Devaki Surasi discussing combination sequencing for PSMA-based therapy in advanced disease. Dr. Surasi started with ...

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...

ASCO 2021: Diagnostic Performance of Ga-68 PSMA PET/CT Imaging In Early-Relapsed Prostate Cancer: Phase 3, Prospective ... Safety and Efficacy Outcomes with Nivolumab plus Ipilimumab in Patients with ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

A new report shows while cancer death rates among Black people are declining, they remain higher than other racial and ethnic ...